Shervin Rahimpour

Assistant Professor

University of Utah
Country flagUnited States
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (10)

Roughly one-third of patients with major depressive disorder (MDD) fail to respond to standard treatments and develop treatment-resistant MDD. For these patients, alternative therapies ofer additional options but yield inconsistent outcomes. Progress has been limited by the absence of objective, brain-based biomarkers to guide target selection or track therapeutic response in real time. Instead, clinicians rely on behavioral assessments that evolve slowly over weeks to months, obscuring the underlying neural dynamics of symptom changes. Here, we test whether the aperiodic exponent of intracranial EEG (iEEG) local field potentials can serve as a neurophysiological marker of depression symptom severity. We leveraged a large iEEG cohort (N = 20) undergoing invasive monitoring for refractory epilepsy, yielding over 1,800 contacts spanning cortical and subcortical zones. For each contact, we estimated the aperiodic exponent (thought to reflect aspects of cortical excitability) of the power spectrum across 10-100 Hz within local brain regions and across distributed cortical association networks. Depressive symptoms were assessed with the Beck Depression Inventory-II (BDI-II) immediately before intracranial resting state recordings. With respect to the BDI-II scale, participants were identified as experiencing minimal (BDI-II ≤ 13) or elevated depression symptoms (BDI-II ≥ 14). Associations between symptom severity (BDI-II total score and Somatic-Afective, Cognitive, and Anhedonia subscales) and region- or network-level exponents were modeled with ordinary least squares (OLS) regression. The whole-brain, mean aperiodic exponent for each participant discriminated symptom status (AUC = 0.81). At the regional level, the orbitofrontal cortex, anterior cingulate cortex, insula, and amygdala showed higher exponents in the elevated depression symptom group (d = 1.18-1.71; p = 0.032-0.004). A post-hoc classification analysis across these four regions misclassified one participant per group (AUC = 0.86; 95% CI 0.64-1.00). In continuous analyses, BDI-II scores correlated positively with exponents in these same four regions (pFDR = 0.019-0.027; partial r=0.61–0.70) and at the network level in the Salience network (pFDR = 0.024; partial r = 0.63) and Default (pFDR = 0.046; partial r = 0.55) network. The Salience network significantly tracked Anhedonia symptoms (p = 0.004; partial r = 0.62). Here we report that intracranial aperiodic exponents within fronto-limbic and insular circuits, overlapping with networks implicated in contemporary accounts of depression pathophysiology, diferentiate depressive symptom status and scale with severity. These findings support the aperiodic exponent as a candidate neurophysiological marker of current depression symptom burden, with potential relevance for individualized neuromodulation in MDD.

Year:

2025

Objective To characterize the type and distribution of epileptiform activity across anatomical regions and functional networks in a large cohort of patients with drug-resistant epilepsy (DRE) undergoing intracranial electroencephalography (iEEG). Methods We retrospectively reviewed iEEG recordings from 93 patients with DRE who underwent stereoelectroencephalography at our institution between 2019 and 2025. Epileptiform activity was classified as “ictal”, “interictal”, or “ictal spread” based on visual inspection and clinical correlation. Electrode coordinates were localized to anatomical regions using the Brainnetome Atlas and to functional networks using the DU15NET-Consensus Atlas . The distribution of epileptiform activity across regions and networks was compared with global baselines using Chi-square tests with false discovery rate correction. Results Interictal discharges were the most prevalent type of epileptiform activity (median 9.5% of contacts per patient), followed by ictal (6.0%) and ictal spread (2.1%). Temporal regions exhibited an increased prevalence of all types of epileptiform activity compared to the global baseline, whereas frontal regions showed marked reductions, despite dense sampling. At the network level, epileptiform activity was overrepresented in Default Network-A and underrepresented in the Salience/Parietal Memory Network. Significance Epileptiform activity shows consistent, non-uniform patterns across both anatomical regions and functional networks. These findings reinforce the central role of the temporal lobe and associative networks in epileptogenesis and support the view of epilepsy as a disorder of distributed brain networks. Mapping epileptiform activity in a network framework may enhance biomarker development and inform circuit-based surgical and neuromodulatory treatment strategies.

Year:

2025

Background: Psychiatric neurosurgery has been shaped by an ethically complex history and rapid evolution in neurotechnology. In the modern era, there is a growing need to match the accelerating pace of scientific innovation with rigorous, contemporary ethical frameworks that prioritize patient autonomy, safety, and maintaining public trust. Summary: In this article, we review 21st-century approaches to neurosurgery for psychiatric disorders that combine the precision of modern functional neurosurgery with advances in diagnostic and therapeutic neurotechnology. The ethical issues in contemporary psychiatric neurosurgery are multifaceted and evolving, reflecting the intersection of rapid scientific progress, changing societal values, and a controversial past. Key Messages: The four core principles of medical ethics – beneficence, nonmaleficence, autonomy, and justice – and their application to psychiatric neurosurgery are discussed in the context of existing and anticipated ethical issues (e.g., post-trial responsibilities in research, informed consent, disparities in access to care). Finally, we explore how technological breakthroughs, coupled with growing market investment and consumer interest in the field, establish a compelling need to develop robust, forward-looking regulatory frameworks that are aligned with these bioethical principles.

Year:

2025

BACKGROUND AND OBJECTIVES: Trigeminal neuralgia causes debilitating facial pain. Treatments, including decompression, radiosurgery, and minimally invasive percutaneous procedures such as mechanical compression, are low risk and offer immediate relief, making them a preferred option. Successful percutaneous treatment depends on safely and successfully accessing the foramen ovale. This study evaluated a novel electromagnetic (EM)-guided cannula used for percutaneous trigeminal rhizotomy. METHODS: The cannula's accuracy and EM neuronavigation compatibility were evaluated in a cadaveric study. Subsequently, we evaluated a retrospective series of patients who underwent percutaneous trigeminal rhizotomy between June 2017 and April 2024 using either the novel cannula or a traditional method using fluoroscopic guidance. The exposure variables included preoperative characteristics, comorbidities, and intraoperative variables such as operation duration, balloon inflation time, and fluoroscopy exposure. Primary outcomes were pain relief, assessed using the Barrow Neurological Institute score for trigeminal neuralgia pain at immediate postoperative, 4-month, and last follow-up time points, and pain recurrence during follow-up. RESULTS: The cadaveric testing had a 100% cannulation success rate, with millimeter precision from the stylet to the center of the foramen ovale. A total of 61 percutaneous trigeminal rhizotomy procedures with a mean follow-up of 8.5 ± 9.9 months were studied. The EM navigation technique was used in 28 and conventional fluoroscopic guidance in 33. Fluoroscopy exposure time was significantly lower with EM navigation (1.3 ± 0.6 minutes vs 7.0 ± 3.8 minutes; P < .001). Multivariable regression analysis found no difference in patient outcomes between the 2 techniques. CONCLUSION: The EM-guided cannula may assist surgeons in performing trigeminal rhizotomies accurately and efficiently while also reducing operation time and radiation exposure.

Year:

2025

Cortical neural activity varies dynamically during memory periods, when relevant information is not present in the environment. But how those dynamics are related to a code defining working memory (WM) performance is not known. Recent data shows brief bursts of activity in the high gamma (70-140 Hz) and beta (12-30 Hz) band within non-human primate lateral prefrontal cortex (PFC) is associated with WM processing. However, WM may be related to activity within a network of frontal executive and posterior sensory areas involved in stimulus perception. Here we tested whether gamma and beta bursting exist in lateral PFC and multisensory lateral temporal areas in humans during visual WM, and whether these areas are coupled via a phase-burst code. We used intracranial macroelectrode recordings from the middle frontal gyrus (MFG), which includes dorsolateral PFC, and from the middle temporal gyrus (MTG), an area important for visual processing. High gamma bursting increased in human left PFC during encoding and delay periods while beta bursting decreased. Interestingly, beta bursting increased in multisensory areas during encoding and remained high during the delay period, more so on the right. These effects varied with WM performance. Finally, we quantify the degree to which delay-period gamma bursting is locked to beta phase within and between regions of this network using a proposed metric termed ‘phase-burst coupling’ (PBC). We find evidence that delay-period gamma bursting in temporal areas is locked to beta phase in PFC. Our findings suggest that WM may use bursting to support memory maintenance until readout. Significance Statement Working memory is critical for everyday functioning and its disruption results in significant disability in patients with dementia, traumatic brain injury, and stroke. We recorded human intracranial data during a visual working memory task. We found that prefrontal cortex and multisensory temporal brain areas show neural bursting activity during the memory period and that such bursting is related to trial performance. Furthermore, these two areas may be coupled by a phase-burst code. Bursting has been found in non-human primates, rodents, and even crows, suggesting it is a general feature of memory, and perhaps of other aspects of cognition.

Year:

2025

The ability to think creatively is fundamental to human cognition, shaping how we interact with the world and navigate complex problems. Creativity depends on the interaction of multiple large-scale brain networks, but how these networks represent creative thought and distinguish it from other cognitive states remains unclear. Here, we use invasive intracranial recordings in the human brain to explore the network-level representations underlying creative thinking. Our results demonstrate that cortical networks in the human brain differentially encode distinct cognitive states: we found unique brain states underlying creative thinking vs. arithmetic calculations, particularly in the default mode network. Further, in the dorsal attention network, we uncovered nonlinear, high-dimensional representations of moment-by-moment fluctuations in creative performance. These representations define a neural creativity axis shared between network-level and single-neuron computations. Our findings reveal widespread neural representations of cognitive state and suggest distinct roles of specific cortical networks in controlling creativity, with the default mode network gating access to creative states and the dorsal attention network regulating the quality of creative output.

Year:

2025

Seizure termination has been linked to spreading depolarizations (SDs) in experimental epilepsy models, and SDs have recently been suggested to protect against seizures. The precise mechanism, however, remains unclear. Additionally, the co-occurrence of SDs with human seizures remains debated. In this study, we found that SDs are a prominent feature following ictal events in both human clinical recordings (n=20 seizures from 7 epilepsy patients) using direct-current amplifiers and in the 0 Mg 2+ model of ictogenesis from rodent brain slices (n=17). Approximately one-third of rodent seizure-like events (SLEs) were associated with SDs, while all human seizures analyzed had associated infraslow shifts, a hallmark of SDs. SDs were more prominent in the lateral frontal, medial frontal, and lateral temporal lobes, as well as the insular cortex in human patients, but were observed in all recorded brain regions. In rodents, SDs clustered toward the end of ictal events, resulting in significantly shorter SLEs (SLE without SD: 32.60 ± 5.31 s; SLE with SD: 16.03 ± 4.45 s) and delayed onset of subsequent SLEs. These SDs also caused significant AC band silencing compared to SLEs without SDs. Interestingly, SLEs with SDs displayed significantly more low gamma activity during ictal events. Using ion- selective microelectrodes, we found no significant correlation between extracellular [K + ] levels and SLEs ending in SDs, questioning the role of [K + ] o in SD induction during seizures. We observed more heterogeneity in human seizures than in rodent SLEs, with some human seizures showing SD-associated termination and others demonstrating SDs in the middle of ictal events; such intra-seizure SDs were never observed in our rodent model. The human data, collected from patients with intractable epilepsy, demonstrate clear SD propagation during seizures and show that SDs appear and propagate, in multiple brain regions simultaneously with ictal events. Collectively, these results indicate that SDs are a hallmark of ictal activity and may contribute to seizure termination in both experimental and clinical settings. Furthermore, these findings provide unique insight into the neuronal dynamics that promote SD induction by showing that increased low gamma activity during SLEs is more predictive of SD induction than extracellular [K + ] levels. We also add further support for the hypothesis that SDs are both anti- seizure and anti-ictogenic as they not only limit and delay subsequent ictal activity but also reduce the duration of SLEs. Taken together, these findings provide rationale for further exploration of SDs as a means to prematurely terminate life-threatening seizures.

Year:

2025

Neuromodulation techniques, such as deep brain stimulation, intraoperative brain mapping, and responsive neurostimulation, use electricity to alter brain activity. Despite daily clinical use in thousands of patients, it remains fundamentally unknown how human neurons respond to intracranial stimulation. We address this question at a basic level by characterizing neuronal cell-type specific firing rate responses to single pulses of electrical stimulation of the human brain. We carried out broadly distributed stimulation in 30 patients undergoing neuromonitoring for epilepsy while recording from isolated neurons on microwires implanted into the medial temporal and frontal lobes. Out of a total of 228 recorded units, 16.2% (N = 191) were classified as interneurons and 83.8% (N = 37) were classified as principal cells, using a threshold clustering method, based on intrinsic waveshape characteristics. To see how stimulation affected neuronal activation for each cell type, we calculated firing rate change between a pre-stimulation and post-stimulation window and observed that 174 units were significantly modulated with the vast majority (91%) showing firing rate suppression. We then characterized stimulation-evoked changes in firing rate to gain insight into cell type-specific responses. Additionally, in a subset of the units, we observed that firing rate responses were modulated by stimulation distance, where local stimulation (within approximately 40 mm) could evoke instantaneous firing, whereas distant stimulation reliably suppressed firing in the same units. Finally, we analyzed a subset of units within the seizure onset zone, which exhibited unique waveform features and responses to stimulation. This study bridges a gap in the neuromodulation field by examining the single-unit firing rate response to direct electrical stimulation of the human brain and analyzing cell-type specific firing rate responses. We show that low frequency, single-pulse stimulation broadly elicits firing rate suppression, but parameters, such as distance from the unit, can have diverse effects on firing rate responses. This work informs the neuronal basis of CCEP generation and therefore has implications for clinical mapping and informs novel ‘active probing’ strategies for precision diagnosis and neuromodulation of seizure pathophysiology in surgical cases. Moreover, this research has general implications for understanding neuromodulation via direct brain stimulation. Highlights - Putative principal cell waveform shapes are characterized by longer trough-to-peak and full-width half max durations (s) compared to interneurons. - Monopolar stimulation @ 3 mA generally has a widespread suppressive effect on neuronal firing, lasting approximately 1.5 s. - Principal cells show greater suppression amplitude and longer suppression durations than interneurons. - Stimulation within ∼ 40 mm is capable of evoking instantaneous firing, despite general suppression from stimulation at greater distances.

Year:

2024

Impulsive choices prioritize smaller, more immediate rewards over larger, delayed, or potentially uncertain rewards. Impulsive choices are a critical aspect of substance use disorders and maladaptive decision-making across the lifespan. Here, we sought to understand the neuronal underpinnings of expected reward and risk estimation on a trial-by-trial basis during impulsive choices. To do so, we acquired electrical recordings from the human brain while participants carried out a risky decision-making task designed to measure choice impulsivity. Behaviorally, we found a reward-accuracy tradeoff, whereby more impulsive choosers were more accurate at the task, opting for a more immediate reward while compromising overall task performance. We then examined how neuronal populations across frontal, temporal, and limbic brain regions parametrically encoded reinforcement learning model variables, namely reward and risk expectation and surprise, across trials. We found more widespread representations of reward value expectation and prediction error in more impulsive choosers, whereas less impulsive choosers preferentially represented risk expectation. A regional analysis of reward and risk encoding highlighted the anterior cingulate cortex for value expectation, the anterior insula for risk expectation and surprise, and distinct regional encoding between impulsivity groups. Beyond describing trial-by-trial population neuronal representations of reward and risk variables, these results suggest impaired inhibitory control and model-free learning underpinnings of impulsive choice. These findings shed light on neural processes underlying reinforced learning and decision-making in uncertain environments and how these processes may function in psychiatric disorders.

Year:

2024

Background Essential tremor (ET) is a movement disorder that affects 4%–5% of adults >65 years. For patients with medically refractory ET, neurosurgical interventions such as deep brain stimulation (DBS) and unilateral MR-guided focused ultrasound thalamotomy (MRgFUS) are available. In this retrospective cohort study, we examined the demographics of patients with ET who have received MRgFUS and evaluated trends in DBS usage in the USA after the introduction of MRgFUS in 2016. Methods We used multiple databases to examine the demographics of patients who received DBS and MRgFUS, and trends in DBS. To assess the demographics, we queried the TriNetX database from 2003 to 2022 to identify patients diagnosed with ET and stratify them by DBS or MRgFUS treatment by using Current Procedural Terminology codes. Patient demographics were reported as frequencies and percentages. To examine the trends in DBS for ET, the yearly frequency of DBS procedures done for ET between 2012 and 2019 was extracted from the National Inpatient Sample (NIS) database, and breakpoint analysis was performed. Additionally, the yearly frequency of MRgFUS procedures for ET was obtained from Insightec Exlabate. Results Most of the patients (88.69%) in the cohort extracted from TriNetX database self-identified as white, followed by black or African American (2.40%) and Asian (0.52%). A higher percentage of black patients received MRgFUS treatment than DBS (4.10% vs 1.88%). According to the NIS database, from 2012 to 2020, 13 525 patients received DBS for ET. Conclusion This study provides an overview of the characteristics of patients who undergo DBS or MRgFUS. We found notable differences in sex and race among patients who underwent each treatment type. Additionally, until at least the beginning of 2020, the number of DBS procedures for ET was not negatively affected after the introduction of MRgFUS.

Year:

2024

Collaborators (14)

Wendy Sun

Harvard University

UNITED STATES
View details

Eleonora Bartoli

Assistant Professor

Baylor College of Medicine

UNITED STATES
View details

Ben Shofty

-

UNITED STATES
View details

Sameer Sheth

Baylor College of Medicine

UNITED STATES
View details

Roger Beaty

Assistant Professor

Pennsylvania State University

UNITED STATES
View details

Andrew Trevelyan

Professor of Network Neuroscience

Newcastle University

UNITED KINGDOM
View details

John D Rolston

Brigham and Women's Hospital

UNITED STATES
View details

Satish S. Nair

Professor

University of Missouri Columbia

UNITED STATES
View details

Bornali Kundu

Assistant Professor

University of Missouri

UNITED STATES
View details

Jingnan Du

Assistant Professor

University of Notre Dame

UNITED STATES
View details

R Ryley Parrish

Brigham Young University

UNITED STATES
View details

Elliot Smith

Assistant Professor

University of Utah

UNITED STATES
View details

Juha Voipio

University of Helsinki

FINLAND
View details

Randy Buckner

Solsland Family Professor of Psychology and Neuroscience

Harvard University

UNITED STATES
View details